EUVIMEDEUVIMED entdecken
Crossref

Towards Sensitive and Cost‐Effective Chimerism Assays Using FABCASE : A Fast Approach for Estimating Assay Informativity

Matthijs Vynck iD

International Journal of Laboratory Hematology · 2025

DOI: 10.1111/ijlh.14460 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2025. Verfasst von Matthijs Vynck. Beteiligte Einrichtung: Cancer Research Institute Ghent, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Chimerism, Transplantation Chimera. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chimerism monitoring is part of the standard of care for patients following an allogeneic hematopoietic stem cell transplantation. There has recently been a move towards sensitive, high‐throughput (next‐generation) sequencing analysis of biallelic markers for this purpose. Determining the number and properties of the markers to include in an assay to achieve reliable yet cost‐effective chimerism quantification is an underexposed but critical part of chimerism assay development, optimization, and validation.

Methods

We develop FABCASE (Fast and Accurate Biallelic Chimerism Assay Size Estimation), an approach to estimate the required number of markers to screen to obtain a given informativity rate. We explore several practical examples that illustrate the diverse applications of FABCASE beyond calculating the required number of markers to screen.

Results

FABCASE offers a more than four orders of magnitude speed improvement compared to a previously introduced Monte Carlo simulation approach, unlocking extensive in silico scenario analyses. We find that minor allele frequency ( MAF ) and informative rate estimation based on small sample series (tens) are reasonably accurate. MAFs may vary drastically between populations, and the number of required markers to attain a preset informativity rate is inflated (here, +28%) when not optimized. Marker subset selection from a pool of candidate markers is little impacted by small‐to‐medium MAF differences (0%–20% MAF ). Prioritizing markers with uniform amplification efficiency reduces sequencing depth requirements and improves cost‐effectiveness. A web graphical user interface facilitating marker set informativity evaluation is available at https://mvynck.shinyapps.io/FABCASE .

Conclusion

FABCASE facilitates the design, refinement, and implementation of sensitive and cost‐effective chimerism assays. Due attention should be given to an assay's marker MAFs , sensitivities, and amplification efficiencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingChimerismTransplantation ChimeraHumansCost-Benefit AnalysisHematopoietic Stem Cell TransplantationGene FrequencyAllelesGenetic Markers

Stichwörter der Autor:innen

allogeneic stem cell transplantationassay designchimerismnumber of markerssensitive

Substanzen

Genetic Markers

Autor:innen und Institutionen

  • Cancer Research Institute Ghent, Ghent University, Ghent, Belgium.
  • Digital PCR Center, Ghent University, Merelbeke, Belgium.

ORCID-Profile: Matthijs Vynck

Zitieren

APA

Vynck, M. (2025). Towards Sensitive and Cost‐Effective Chimerism Assays Using FABCASE : A Fast Approach for Estimating Assay Informativity. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14460

Vancouver

Vynck M. Towards Sensitive and Cost‐Effective Chimerism Assays Using FABCASE : A Fast Approach for Estimating Assay Informativity. International Journal of Laboratory Hematology. 2025. doi:10.1111/ijlh.14460

BibTeX
@article{Vynck2025,
  author = {Vynck, Matthijs},
  title = {Towards Sensitive and Cost‐Effective Chimerism Assays Using FABCASE : A Fast Approach for Estimating Assay Informativity},
  journal = {International Journal of Laboratory Hematology},
  year = {2025},
  doi = {10.1111/ijlh.14460}
}
Kostenlos starten →